Ribosomal protein L39 pseudogene 34 (RPL39P34)

Ribosomal protein L39 pseudogene 34 (RPL39P34) is a human pseudogene, meaning it is a genomic DNA sequence similar to the ribosomal protein L39 gene but does not encode a functional protein and has no known physiological or pathological role. It carries the numeric designation “34” to distinguish it from other pseudogenes related to RPL39, reflecting the presence of many such copies in the genome[4][7]. Essential Context and Supporting Details Pseudogene status: RPL39P34 is explicitly labeled in gene databases as a pseudogene, with no protein product and no described function or disease involvement[4][7]. Therapeutic relevance: This gene is not a receptor, enzyme, transporter, or any other conventional therapeutic target, and no drugs are known to interact with it, nor is it established as a biomarker or safety concern. Nomenclature correctness: While the given name and abbreviation are correct for the pseudogene, it is important to note that pseudogenes do not encode active targets; its “target” status would be incorrect except in the special case of research into non-coding or regulatory elements (not established here)[4][7]. Overlap with protein-coding gene: RPL39 (without the “P” and number) is a different, functional gene encoding a ribosomal protein that is essential for protein synthesis[1][2]. In contrast, RPL39P34 is one of many non-functional copies (processed pseudogenes) present in the human genome. If your workflow is seeking drug targets or active protein-coding genes, RPL39P34 is not a suitable candidate. It is important not to conflate this with the functional ribosomal protein L39 gene (RPL39)[1][2][4].